» Articles » PMID: 28296209

The Urinary H-NMR Metabolomics Profile of an Italian Autistic Children Population and Their Unaffected Siblings

Overview
Journal Autism Res
Specialty Psychiatry
Date 2017 Mar 16
PMID 28296209
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Autism spectrum disorders (ASD) make a dishomogeneous group of psychiatric diseases having either genetic and environmental components, including changes of the microbiota. The rate of diagnosis, based on a series of psychological tests and observed behavior, dramatically increased in the past few decades. Currently, no biological markers are available and the pathogenesis is not defined. The purpose of this study was to evaluate the potential use of H-NMR metabolomics to analyze the global biochemical signature of ASD patients (n = 21) and controls (n = 21), these being siblings of autistic patients. A multivariate model has been used to extrapolate the variables of importance. The discriminating urinary metabolites were identified; in particular, significantly increased levels of hippurate, glycine, creatine, tryptophan, and d-threitol and decreased concentrations of glutamate, creatinine, lactate, valine, betaine, and taurine were observed in ASD patients. Based on the identified discriminant metabolites, the attention was focused on two possible mechanisms that could be involved in ASD: oxidative stress conditions and gut microflora modifications. In conclusion, nuclear magnetic resonance-based metabolomics analysis of the urine seems to have the potential for the identification of a metabolic fingerprint of ASD phenotypes and appears to be suitable for further investigation of the disease mechanisms. Autism Res 2017. © 2017 International Society for Autism Research, Wiley Periodicals, Inc. Autism Res 2017, 10: 1058-1066. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.

Citing Articles

Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy.

Zhuang H, Liang Z, Ma G, Qureshi A, Ran X, Feng C MedComm (2020). 2024; 5(3):e497.

PMID: 38434761 PMC: 10908366. DOI: 10.1002/mco2.497.


Host-microbiome orchestration of the sulfated metabolome.

DAgostino G, Chaudhari S, Devlin A Nat Chem Biol. 2024; 20(4):410-421.

PMID: 38347214 PMC: 11095384. DOI: 10.1038/s41589-023-01526-9.


Metabolomics: Perspectives on Clinical Employment in Autism Spectrum Disorder.

Siracusano M, Arturi L, Riccioni A, Noto A, Mussap M, Mazzone L Int J Mol Sci. 2023; 24(17).

PMID: 37686207 PMC: 10487559. DOI: 10.3390/ijms241713404.


Investigating the Urinary Metabolome in the First Year of Life and Its Association with Later Diagnosis of Autism Spectrum Disorder or Non-Typical Neurodevelopment in the MARBLES Study.

Sotelo-Orozco J, Schmidt R, Slupsky C, Hertz-Picciotto I Int J Mol Sci. 2023; 24(11).

PMID: 37298406 PMC: 10254021. DOI: 10.3390/ijms24119454.


An Overview on Fecal Profiles of Amino Acids and Related Amino-Derived Compounds in Children with Autism Spectrum Disorder in Tunisia.

Chamtouri M, Merghni A, Salazar N, Redruello B, Gaddour N, Mastouri M Molecules. 2023; 28(7).

PMID: 37050030 PMC: 10096484. DOI: 10.3390/molecules28073269.